Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based Questionnaire A Validation Study in The Netherlands

被引:48
|
作者
van Gelder, Marleen M. H. J. [1 ]
van Rooij, Iris A. L. M. [1 ]
de Walle, Hermien E. K. [2 ]
Roeleveld, Nel [1 ]
Bakker, Marian K. [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6500 HB Nijmegen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Eurocat Northern Netherlands, Groningen, Netherlands
关键词
DRUG-USE; BIRTH-DEFECTS; PHARMACY RECORDS; MOTHERS; EXPOSURE; BIAS; INFORMATION; DELIVERY; COHORT; WOMEN;
D O I
10.1007/s40264-012-0004-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background In case-control studies that assess associations between medication use and birth defects, detailed information on type of medication and timing of use is essential to prevent misclassification. However, data on the accuracy of recall of medication use during pregnancy are scarce. Objective The aim of this study was to validate a self-administered questionnaire to assess prescription medication use in the 3 months before and during pregnancy. Methods This validation study was embedded in Eurocat Northern Netherlands, a population-based birth defects registry that covers 10 % of all births in The Netherlands. The questionnaire was validated among 560 mothers of infants with major birth defects registered from 1 January 2009 through 30 June 2010 by comparing it with a reference standard consisting of pharmacy data which were checked for compliance by maternal interviews. Sensitivity and specificity were calculated to quantify validity for any prescription medication use, groups of medications and individual medications. In addition, we determined whether maternal characteristics influenced disagreement between the questionnaire and the reference standard using logistic regression analyses. Results The sensitivity for any prescription medication use was 0.57, ranging between 0.07 (dermatological corticosteroids) and 0.83 (antihypertensives) for medication groups, and between 0.00 (naproxen) and 0.73 (salbutamol) for individual medications. Overall, specificity was high (0.93-1.00). Smoking during pregnancy and completing the questionnaire >2 years after delivery were associated with increased disagreement between the questionnaire for prescription medication use and the reference standard. Conclusions The validity of the self-administered questionnaire for prescription medication use during pregnancy was moderate to poor for most medications and disagreement differed by some maternal characteristics. As many epidemiological studies use similar questionnaires to assess medication use these studies may need additional data sources such as pharmacy records or prescription databases for medication use next to self-reported methods. Also, previous knowledge on the effect of questionnaire design should be taken into account.
引用
收藏
页码:43 / 54
页数:12
相关论文
共 50 条
  • [1] Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based QuestionnaireA Validation Study in The Netherlands
    Marleen M. H. J. van Gelder
    Iris A. L. M. van Rooij
    Hermien E. K. de Walle
    Nel Roeleveld
    Marian K. Bakker
    Drug Safety, 2013, 36 : 43 - 54
  • [2] VALIDITY AND RELIABILITY OF MATERNAL RECALL OF PRESCRIPTION DRUG USE DURING PREGNANCY
    van Gelder, M.
    van Rooij, I.
    de Walle, H.
    Roeleveld, N.
    Bakker, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S76 - S76
  • [3] Validity and Reliability of Maternal Recall of Prescription Drug Use during Pregnancy
    van Gelder, Marleen M. H. J.
    van Rooij, Iris A. L. M.
    de Walle, Hermien E. K.
    Roeleveld, Nel
    Bakker, Marian K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S124 - S125
  • [4] Medication use during pregnancy in the Netherlands: A population-based study
    Houben, E.
    Bezemer, I. D.
    Hukkelhoven, C. W.
    Steegers, E. A. P.
    Herings, R. M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 229 - 229
  • [5] MEDICATION USE DURING PREGNANCY IN THE NETHERLANDS: A POPULATION-BASED STUDY
    Houben, E.
    Bezemer, I
    Hukkelhoven, C.
    Steegers, E.
    Herings, R.
    VALUE IN HEALTH, 2017, 20 (09) : A525 - A525
  • [6] Validation of maternal recall of early pregnancy medication exposure using prospective diary data
    Sundermann, Alexandra C.
    Hartmann, Katherine E.
    Jones, Sarah H.
    Torstenson, Eric S.
    Edwards, Digna R. Velez
    ANNALS OF EPIDEMIOLOGY, 2017, 27 (02) : 135 - 139
  • [7] Prescription medication use during pregnancy in France between 2010 and 2022: A nationwide study
    Miranda, Sara
    Herlemont, Philippe
    Drouin, Jerome
    Weill, Alain
    Dray-Spira, Rosemary
    NEUROTOXICOLOGY AND TERATOLOGY, 2024, 104
  • [8] Prescription Medication Use During Pregnancy in France Between 2010 and 2022: A Nationwide Study
    Miranda, Sara
    Herlemont, Philippe
    Drouin, Jerome
    Weill, Alain
    Dray-Spira, Rosemary
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 94 - 94
  • [9] Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study
    Thunbo, Mette ostergaard
    Vendelbo, Julie Hauer
    Witte, Daniel R.
    Larsen, Agnete
    Pedersen, Lars Henning
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2025, 136 (04)
  • [10] Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study
    Camden, Andi
    Grandi, Sonia M.
    Lunsky, Yona
    Ray, Joel G.
    Sharpe, Isobel
    Lu, Hong
    Guttmann, Astrid
    Tailor, Lauren
    Vigod, Simone
    De Vera, Mary A.
    Brown, Hilary K.
    JOURNAL OF WOMENS HEALTH, 2024, 33 (09) : 1224 - 1232